期刊文献+

子宫内膜异常增生74例相关因素分析 被引量:7

下载PDF
导出
摘要 目的探讨引起子宫内膜异常增生的高危因素。方法选择北京大学人民医院妇科自2006年3月至2008年3月收治的行子宫切除术、诊断性刮宫术治疗或宫腔镜检查及治疗的并经病理证实的子宫内膜增生症患者74例,并选取同期诊治的其他妇科良性疾病并无子宫内膜增生症患者76例为对照组,对比分析与子宫内膜增生症可能相关的高危因素。结果研究结果显示,子宫内膜异常增生患者的孕次显著低于无子宫内膜增生症患者(P=0.02),但分娩次数两组之间差异无显著性(P=0.87);子宫内膜异常增生组患者体质量指数明显高于对照组(P=0.03);子宫内膜异常增生与多囊卵巢综合征、卵巢良性肿物、内膜息肉、子宫内膜异位症均有统计相关性,并与肝病相关(P值均<0.05)。结论子宫内膜异常增生患者常有明显的高危因素,重视高危因素有助于本病的预防及早期诊治。
出处 《中国医药指南》 2010年第5期67-69,共3页 Guide of China Medicine
  • 相关文献

参考文献12

  • 1Horn L,Meinel A,Handzel R,et al.Histopathology of endometrial hyperplasia and endometrial carcinoma: an update[J].Ann Diagn Pathol,2007,11 (4): 297-311. 被引量:1
  • 2Lacey JV Jr, Ioffe OB,Ronnett BM,et al. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan[J].Br J Cancer, 2008,98(1): 45-53. 被引量:1
  • 3Lai CH,Huang HJ. The role of hormones for the treatment of endo- metrial hyperplasia and endometrial cancer[J]. Curr Opin Obstet Gynecol,2006,18(1): 29-34. 被引量:1
  • 4Baandersvan Halewyn EA,Blankenstein MA,Thijssen JHH,et al. A comparative study of risk factors for hyperplasia and cancer of the endometrium[J]. Eur J Cancer Prey, 1996,5 (2) : 105-112. 被引量:1
  • 5Viola AS,Gouveia D,Andrade L,et al.Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women[J]. Aust N Z J Obstet Gynaecol,2008,48(2): 207-213. 被引量:1
  • 6Navaramarajah R,Pillay OC,Hardiman RPolycystic ovary syndrome and endometrial cancer[J].Semin Reprod Med,2008,26(1): 62-71. 被引量:1
  • 7Harade T, Kaponis A,Ivabe T, et al. Apoptosis in human endometrittm and endometriosis[J]. Hum Reprod Update,2004,10( 1):29-38. 被引量:1
  • 8杨雪峰.围绝经期功能失调性子宫出血患者子宫内膜bcl-2基因的表达[J].中华妇产科杂志,2002,37(3):180-181. 被引量:13
  • 9Hachisuga T, Miyawa T, Tsujioka H,et al.K-ras mutation in tamoxifen- related endometrial polyps[J].Cancer,2003,98(9): 1890-1897. 被引量:1
  • 10Ansbacher R,Advincula AP.Endometrial polyp secondary to tamoxifen therapy[J]. Fertil Steril,2003,80(1):216-217. 被引量:1

二级参考文献3

共引文献12

同被引文献34

  • 1Navaratnarajah R, Pillay OC. Polycystic ovary syndrome and endometrial cancer [J]. Semin Reprod Med, 2008, 26 (1) : 62. 被引量:1
  • 2Horn LC,,Meinel A.Histopathology of endometrial hyperplasia and endometrial carcinoma:an update. Annals of Diagnostic Pathology . 2007 被引量:1
  • 3Lacey JV,Ioffe OB.Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia:the34-year experience in a large health plan. British Journal of Cancer . 2008 被引量:1
  • 4Viola AS,Gouveia D.Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women. Australian Journal of Obstetrics and Gynecology . 2008 被引量:1
  • 5Guttinger A,Critchley HOD.Endometrial effects of intrauterine levonorgestrel. Contraception . 2007 被引量:1
  • 6Navaratnarajah R,Pillay OC,Hardiman P.Polycystic ovary syndrome and endometrial cancer. Seminars in Reproductive Medicine . 2008 被引量:1
  • 7F Linkov,R Edwards,J Balk.Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. European Journal of Cancer . 2008 被引量:1
  • 8Wildemeersch D,Janssens D,Pylyser K,et al.Management of pa-tients with non-atypical and atypical endometrial hyperplasia with alevonorgestrel-releasing intrauterine system:long-term follow-up. Maturitas . 2007 被引量:1
  • 9高辉,郁琦.典型子宫内膜增生临床病例解析[J].中国处方药,2009,8(3):78-79. 被引量:1
  • 10陈玲玲.68例子宫内膜癌临床分析[J].当代医学,2009,15(23):412-413. 被引量:7

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部